• Profile
Close

Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid cancer

Clinical Endocrinology Jan 19, 2018

Li H, et al. - As a part of this study, experts weighed the impact of radioiodine (RAI) therapy initiating time on the response to initial therapy in patients with low- to intermediate-risk differentiated thyroid cancer (DTC). Based on the results, it was inferred that delayed initial RAI therapy (≥3 months after thyroidectomy) correlated with incomplete response in low- to intermediate-risk DTC patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay